Distribution of Medicinal Products in Light of Non-legislative Regulations and Market Agreements on the Pharmaceutical MarketAleksandra Czerw and Magdalena Bilinska*
Department of Public Health, Medical University of Warsaw, Zwirki I Wigury 61, 02-091 Warszawa, Poland
- *Corresponding Author:
- Magdalena Bilinska
Department Of Public Health
Medical University Of Warsaw
Zwirki I Wigury 61, 02-091 Warszawa, Poland
E-mail: [email protected]
Received Date: September 20, 2013; Accepted Date: October 29, 2013; Published Date: October 31, 2013
Citation: Czerw A, Bilinska M (2013) Distribution of Medicinal Products in Poland - Light of Legislative Regulations. J Stock Forex Trad 3:112. doi: 10.4172/2168-9458.1000112
Copyright: © 2013 Czerw A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Distribution of medicines in Poland is strictly regulated by legal provisions. Non-legislative regulations included in codes of ethical pharmaceutical marketing or market agreements between entities operating in the pharmaceutical sector also play an important role. The aim of this paper is to describe distribution agreements between entities operating in the pharmaceutical sector, voluntary associations of economic entities on this market, and regulations contained in codes of ethics shaping the distribution of medications in Poland. Non-legislative regulations do not create nor clarify the law, they exist to streamline the activities of pharmaceutical market entities and ensure their stronger protection. The fact that entrepreneurs join these initiatives voluntarily indicates an increase in their awareness and concern with the patients’ interest.